Drug Shortage Report for SUBLOCADE
| Report ID | 123461 |
| Drug Identification Number | 02483084 |
| Brand name | SUBLOCADE |
| Common or Proper name | Buprenorphine extended release injection |
| Company Name | INDIVIOR UK LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BUPRENORPHINE |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION (EXTENDED RELEASE) |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 syringe/pouch |
| ATC code | N07BC |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-09-01 |
| Actual start date | 2020-09-01 |
| Estimated end date | 2021-03-09 |
| Actual end date | 2021-03-09 |
| Shortage status | Resolved |
| Updated date | 2021-03-10 |
| Company comments | https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/covid19-interim-order-drugs-medical-devices-special-foods/information-provisions-related-drugs-biocides/tier-3-shortages.html |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | THE CHAPLEO BUILDING, HENRY BOOT WAY HULL, -- UNITED KINGDOM HU4 7DY |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-09-01 | English | Compare |
| v2 | 2020-09-01 | English | Compare |
| v3 | 2020-09-01 | English | Compare |
| v4 | 2020-09-01 | French | Compare |
| v5 | 2020-09-02 | English | Compare |
| v6 | 2020-09-21 | English | Compare |
| v7 | 2020-09-21 | French | Compare |
| v8 | 2021-03-02 | English | Compare |
| v9 | 2021-03-02 | French | Compare |
| v10 | 2021-03-10 | English | Compare |
| v11 | 2021-03-10 | French | Compare |
Showing 1 to 11 of 11